Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017 (2017), Article ID 4387081, 9 pages
https://doi.org/10.1155/2017/4387081
Research Article

Expression and Clinical Significance of ILF2 in Gastric Cancer

1Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China
2Department of Cardiology, Tianjin People’s Hospital, Tianjin, China
3Department of Hematology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China

Correspondence should be addressed to Dong-feng Yu

Received 21 March 2017; Revised 30 May 2017; Accepted 2 July 2017; Published 31 July 2017

Academic Editor: Yuen Yee Cheng

Copyright © 2017 Zi-huan Yin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal, “Global cancer statistics, 2012,” CA: A Cancer Journal for Clinicians, vol. 65, no. 2, pp. 87–108, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. W. Chen, R. Zheng, P. D. Baade et al., “Cancer statistics in China, 2015,” CA: A Cancer Journal for Clinicians, vol. 66, no. 2, pp. 115–132, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. W. Chen, R. Zheng, H. Zeng, and S. Zhang, “The incidence and mortality of major cancers in China, 2012,” Chinese Journal of Cancer, vol. 35, no. 1, p. 73, 2016. View at Publisher · View at Google Scholar
  4. E. C. Smyth, M. Verheij, W. Allum et al., “Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up,” Annals of Oncology, vol. 27, Supplement 5, pp. 38–49, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. J. H. Lee, B. H. Nam, K. W. Ryu et al., “Comparison of outcomes after laparoscopy-assisted and open total gastrectomy for early gastric cancer,” The British Journal of Surgery, vol. 102, no. 12, pp. 1500–1505, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Luo, P. Gao, Y. Song et al., “Clinicopathologic characteristics and prognosis of Borrmann type IV gastric cancer: a meta-analysis,” World Journal of Surgical Oncology, vol. 14, no. 1, p. 49, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Alvarado-Cabrero, S. Gil-Hernandez, A. Ruelas-Perea, D. Villaverde-Rodriguez, J. R. Montes-Ochoa, and R. Medrano-Guzman, “Immunohistochemical assessment of HER2 expression in gastric cancer. A clinicopathologic study of 93 cases,” Cirugia y Cirujanos, vol. 85, no. 3, pp. 193–195, 2017. View at Publisher · View at Google Scholar
  8. G. Jomrich and S. F. Schoppmann, “Targeted therapy in gastric cancer,” European Surgery, vol. 48, no. 5, pp. 278–284, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. Sun and N. Zhang, “Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy,” World Journal of Surgical Oncology, vol. 12, no. 1, p. 397, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Marcoulatos, E. Avgerinos, D. V. Tsantzalos, and N. C. Vamvakopoulos, “Mapping interleukin enhancer binding factor 3 gene (ILF3) to human chromosome 19 (19q11-qter and 19p11-p13.1) by polymerase chain reaction amplification of human-rodent somatic cell hybrid DNA templates,” Journal of Interferon & Cytokine Research, vol. 18, no. 5, pp. 351–355, 1998. View at Publisher · View at Google Scholar
  11. G. Zhao, L. Shi, D. Qiu, H. Hu, and P. N. Kao, “NF45/ILF2 tissue expression, promoter analysis, and interleukin-2 transactivating function,” Experimental Cell Research, vol. 305, no. 2, pp. 312–323, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Guan, N. Altan-Bonnet, A. M. Parrott et al., “Nuclear factor 45 (NF45) is a regulatory subunit of complexes with NF90/110 involved in mitotic control,” Molecular and Cellular Biology, vol. 28, no. 14, pp. 4629–4641, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Kiesler, P. A. Haynes, L. Shi, P. N. Kao, V. H. Wysocki, and D. Vercelli, “NF45 and NF90 regulate HS4-dependent interleukin-13 transcription in T cells,” The Journal of Biological Chemistry, vol. 285, no. 11, pp. 8256–8267, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. H. F. Lin, J. Z. Shao, L. X. Xiang, and H. J. Wang, “Molecular cloning, characterization and expression analysis of grass carp (Ctenopharyngodon idellus) NF45 (ILF2) cDNA, a subunit of the nuclear factor of activated T-cells (NF-AT),” Fish & Shellfish Immunology, vol. 21, no. 4, pp. 385–392, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. T. W. Reichman, L. C. Muniz, and M. B. Mathews, “The RNA binding protein nuclear factor 90 functions as both a positive and negative regulator of gene expression in mammalian cells,” Molecular and Cellular Biology, vol. 22, no. 1, pp. 343–356, 2002. View at Google Scholar
  16. S. Sakamoto, K. Aoki, T. Higuchi et al., “The NF90-NF45 complex functions as a negative regulator in the microRNA processing pathway,” Molecular and Cellular Biology, vol. 29, no. 13, pp. 3754–3769, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. O. Isken, M. Baroth, C. W. Grassmann et al., “Nuclear factors are involved in hepatitis C virus RNA replication,” RNA, vol. 13, no. 10, pp. 1675–1692, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. O. Isken, C. W. Grassmann, R. T. Sarisky et al., “Members of the NF90/NFAR protein group are involved in the life cycle of a positive-strand RNA virus,” The EMBO Journal, vol. 22, no. 21, pp. 5655–5665, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. R. L. Stricker, S. E. Behrens, and E. Mundt, “Nuclear factor NF45 interacts with viral proteins of infectious bursal disease virus and inhibits viral replication,” Journal of Virology, vol. 84, no. 20, pp. 10592–10605, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Cheng, X. Jiang, C. Ding et al., “Expression and critical role of interleukin enhancer binding factor 2 in hepatocellular carcinoma,” International Journal of Molecular Sciences, vol. 17, no. 8, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. Q. Hu, Y. Y. Lu, H. Noh et al., “Interleukin enhancer-binding factor 3 promotes breast tumor progression by regulating sustained urokinase-type plasminogen activator expression,” Oncogene, vol. 32, no. 34, pp. 3933–3943, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. Q. Huang, X. He, X. Qiu et al., “Expression of NF45 correlates with malignant grade in gliomas and plays a pivotal role in tumor growth,” Tumour Biology, vol. 35, no. 10, pp. 10149–10157, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Ni, J. Zhu, J. Zhang et al., “Expression and clinical role of NF45 as a novel cell cycle protein in esophageal squamous cell carcinoma (ESCC),” Tumour Biology, vol. 36, no. 2, pp. 747–756, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Ni, G. Mao, Q. Xue et al., “Upregulated expression of ILF2 in non-small cell lung cancer is associated with tumor cell proliferation and poor prognosis,” Journal of Molecular Histology, vol. 46, no. 4-5, pp. 325–335, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. R. A. Shamanna, M. Hoque, T. Pe’ery, and M. B. Mathews, “Induction of p53, p21 and apoptosis by silencing the NF90/NF45 complex in human papilloma virus-transformed cervical carcinoma cells,” Oncogene, vol. 32, no. 43, pp. 5176–5185, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Wan, C. Gong, L. Ji et al., “NF45 overexpression is associated with poor prognosis and enhanced cell proliferation of pancreatic ductal adenocarcinoma,” Molecular and Cellular Biochemistry, vol. 410, no. 1-2, pp. 25–35, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Li, X. Zou, Y. L. Wu et al., “A comparison between the sixth and seventh editions of the UICC/AJCC staging system for nasopharyngeal carcinoma in a Chinese cohort,” PLoS One, vol. 9, no. 12, article e116261, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Ferlay, I. Soerjomataram, R. Dikshit et al., “Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012,” International Journal of Cancer, vol. 136, no. 5, pp. 359–386, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Imai, N. Oue, M. Nishioka et al., “Overexpression of KIF11 in gastric cancer with intestinal mucin phenotype,” Pathobiology, vol. 84, no. 1, pp. 16–24, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Oue, K. Sentani, N. Sakamoto, and W. Yasui, “Clinicopathologic and molecular characteristics of gastric cancer showing gastric and intestinal mucin phenotype,” Cancer Science, vol. 106, no. 8, pp. 951–958, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. T. E. Graber, S. D. Baird, P. N. Kao, M. B. Mathews, and M. Holcik, “NF45 functions as an IRES trans-acting factor that is required for translation of cIAP1 during the unfolded protein response,” Cell Death and Differentiation, vol. 17, no. 4, pp. 719–729, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. L. López-Fernández, M. Párraga, and J. del Mazo, “Ilf2 is regulated during meiosis and associated to transcriptionally active chromatin,” Mechanisms of Development, vol. 111, no. 1-2, pp. 153–157, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. R. A. Shamanna, M. Hoque, A. Lewis-Antes et al., “The NF90/NF45 complex participates in DNA break repair via nonhomologous end joining,” Molecular and Cellular Biology, vol. 31, no. 23, pp. 4832–4843, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Uchida, K. Uzawa, A. Kasamatsu et al., “Overexpression of cell cycle regulator CDCA3 promotes oral cancer progression by enhancing cell proliferation with prevention of G1 phase arrest,” BMC Cancer, vol. 12, p. 321, 2012. View at Publisher · View at Google Scholar · View at Scopus